TF
VIVO

TimeScale Financial’s Meridian Bioscience Inc VIVO Stock Holding History

TimeScale Financial’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,064
Closed -$65.1K – 672
2022
Q4 		$65.1K Buy
2,064
+1
+0% +$32 0.02% 137
2022
Q3 		$65K Sell
2,063
-1
-0% -$32 0.02% 137
2022
Q2 		$63K Hold
2,064
– – 0.02% 140
2022
Q1 		$54K Hold
2,064
– – 0.01% 166
2021
Q4 		$42K Buy
2,064
+1
+0% +$19 0.01% 182
2021
Q3 		$40K Sell
2,063
-1
-0% -$20 0.01% 186
2021
Q2 		$46K Hold
2,064
– – 0.01% 178
2021
Q1 		$54K Hold
2,064
– – 0.01% 173
2020
Q4 		$39K Hold
2,064
– – 0.01% 171
2020
Q3 		$35K Hold
2,064
– – 0.01% 176
2020
Q2 		$49K Buy
2,064
+1
+0% +$14 0.02% 151
2020
Q1 		$17K Hold
2,063
– – 0.01% 226
2019
Q4 		$20K Sell
2,063
-1
-0% -$9 0.01% 277
2019
Q3 		$20K Hold
2,064
– – 0.01% 281
2019
Q2 		$25K Buy
+2,064
New +$24.9K 0.01% 257

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TimeScale Financial's VIVO Position: Q1 2023 in Review

TimeScale Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,064 shares — an estimated $65.1K sold.

TimeScale Financial first reported a position in VIVO in Q2 2019 and held it in 15 quarters. The position peaked at $65.1K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • TimeScale Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • TimeScale Financial sold 2,064 Meridian Bioscience Inc shares in Q1 2023, an estimated $65.1K.
  • TimeScale Financial first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 15 quarters.
  • TimeScale Financial's Meridian Bioscience Inc position peaked at $65.1K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on TimeScale Financial's 13F filing for Q1 2023, filed 24 Apr 2023.